Cargando…

Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads

INTRODUCTION: A disabling and disfiguring disease that “begins where the road ends”, yaws is targeted by WHO for eradication by the year 2020. The global campaign is not yet financed. To evaluate yaws eradication within the context of the post-2015 development agenda, we perform a somewhat allegoric...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzpatrick, Christopher, Asiedu, Kingsley, Jannin, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177754/
https://www.ncbi.nlm.nih.gov/pubmed/25255131
http://dx.doi.org/10.1371/journal.pntd.0003165
_version_ 1782336829682352128
author Fitzpatrick, Christopher
Asiedu, Kingsley
Jannin, Jean
author_facet Fitzpatrick, Christopher
Asiedu, Kingsley
Jannin, Jean
author_sort Fitzpatrick, Christopher
collection PubMed
description INTRODUCTION: A disabling and disfiguring disease that “begins where the road ends”, yaws is targeted by WHO for eradication by the year 2020. The global campaign is not yet financed. To evaluate yaws eradication within the context of the post-2015 development agenda, we perform a somewhat allegorical cost-effectiveness analysis of eradication, comparing it to a counterfactual in which we simply wait for more roads (the end of poverty). METHODS: We use evidence from four yaws eradication pilot sites and other mass treatment campaigns to set benchmarks for the cost of eradication in 12 known endemic countries. We construct a compartmental model of long-term health effects to 2050. Conservatively, we attribute zero cost to the counterfactual and allow for gradual exit of the susceptible (at risk) population by road (poverty reduction). We report mean, 5(th) and 95(th) centile estimates to reflect uncertainty about costs and effects. RESULTS: Our benchmark for the economic cost of yaws eradication is uncertain but not high –US$ 362 (75–1073) million in 12 countries. Eradication would cost US$ 26 (4.2–78) for each year of life lived without disability or disfigurement due to yaws, or US$ 324 (47–936) per disability-adjusted life year (DALY). Excluding drugs, existing staff and assets, the financial cost benchmark is US$ 213 (74–522) million. The real cost of waiting for more roads (poverty reduction) would be 13 (7.3–20) million years of life affected by early-stage yaws and 2.3 (1.1–4.2) million years of life affected by late-stage yaws. DISCUSSION: Endemic countries need financing to begin implementing and adapting global strategy to local conditions. Donations of drugs and diagnostics could reduce cost to the public sector and catalyze financing. Resources may be harnessed from the extractive industries. Yaws eradication should be seen as complementary to universal health coverage and shared prosperity on the post-2015 development agenda.
format Online
Article
Text
id pubmed-4177754
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41777542014-10-02 Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads Fitzpatrick, Christopher Asiedu, Kingsley Jannin, Jean PLoS Negl Trop Dis Research Article INTRODUCTION: A disabling and disfiguring disease that “begins where the road ends”, yaws is targeted by WHO for eradication by the year 2020. The global campaign is not yet financed. To evaluate yaws eradication within the context of the post-2015 development agenda, we perform a somewhat allegorical cost-effectiveness analysis of eradication, comparing it to a counterfactual in which we simply wait for more roads (the end of poverty). METHODS: We use evidence from four yaws eradication pilot sites and other mass treatment campaigns to set benchmarks for the cost of eradication in 12 known endemic countries. We construct a compartmental model of long-term health effects to 2050. Conservatively, we attribute zero cost to the counterfactual and allow for gradual exit of the susceptible (at risk) population by road (poverty reduction). We report mean, 5(th) and 95(th) centile estimates to reflect uncertainty about costs and effects. RESULTS: Our benchmark for the economic cost of yaws eradication is uncertain but not high –US$ 362 (75–1073) million in 12 countries. Eradication would cost US$ 26 (4.2–78) for each year of life lived without disability or disfigurement due to yaws, or US$ 324 (47–936) per disability-adjusted life year (DALY). Excluding drugs, existing staff and assets, the financial cost benchmark is US$ 213 (74–522) million. The real cost of waiting for more roads (poverty reduction) would be 13 (7.3–20) million years of life affected by early-stage yaws and 2.3 (1.1–4.2) million years of life affected by late-stage yaws. DISCUSSION: Endemic countries need financing to begin implementing and adapting global strategy to local conditions. Donations of drugs and diagnostics could reduce cost to the public sector and catalyze financing. Resources may be harnessed from the extractive industries. Yaws eradication should be seen as complementary to universal health coverage and shared prosperity on the post-2015 development agenda. Public Library of Science 2014-09-25 /pmc/articles/PMC4177754/ /pubmed/25255131 http://dx.doi.org/10.1371/journal.pntd.0003165 Text en © 2014 Fitzpatrick et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fitzpatrick, Christopher
Asiedu, Kingsley
Jannin, Jean
Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title_full Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title_fullStr Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title_full_unstemmed Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title_short Where the Road Ends, Yaws Begins? The Cost-effectiveness of Eradication versus More Roads
title_sort where the road ends, yaws begins? the cost-effectiveness of eradication versus more roads
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177754/
https://www.ncbi.nlm.nih.gov/pubmed/25255131
http://dx.doi.org/10.1371/journal.pntd.0003165
work_keys_str_mv AT fitzpatrickchristopher wheretheroadendsyawsbeginsthecosteffectivenessoferadicationversusmoreroads
AT asiedukingsley wheretheroadendsyawsbeginsthecosteffectivenessoferadicationversusmoreroads
AT janninjean wheretheroadendsyawsbeginsthecosteffectivenessoferadicationversusmoreroads